Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Momenta Pharmaceuticals Announces FDA Approval of ANDA for Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community.
Multigate Quality Doppler Profiles and Morphological/Hemodynamic Alterations in Multiple Sclerosis Patients.
Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration.
Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report.
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.
Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial.
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
The INCAT disability score: A critical analysis of its measurement properties.
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1.
Effect of Treatment Regimen on the Immunogenicity of Human Interferon Beta in Immune Tolerant Mice.
The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.
Daclizumab (anti-CD25) in multiple sclerosis.
Genetics of multiple sclerosis: swimming in an ocean of data.
Genzyme's Lemtrada resubmission accepted for review by FDA
Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients.
Guillain-Barré syndrome: clinical profile and management.
Teaching NeuroImages: MRI in advanced neuromyelitis optica.
[Nicolau syndrome after administration of glatiramer acetate].
Safety issue puts daclizumab in doubt for MS
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes.
The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation.

Pages